great point - have wondered the exact same on a po
Post# of 30025
Quote:
Who says BP is not interested. Maybe AMBS is not interested in BP yet.
...and just not with LymPro, but with PhenoGuard as well, especially when publicising for a Partner 12 months ago:
Quote:
"Coupled with our partnering business model, we believe we will be able to find the appropriate partner for PhenoGuard to fully exploit the true value of this technology."
http://www.thechairmansblog.com/amarantus-bio...6JdXk.dpuf
we all know potential on the overall product line is off the charts - just need one is all - LymPro looks like it is slotted as the 1st revenue generator